Clinical trials
Phase 2 Hemorrhage trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
111 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 12 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 64 |
| Unknown status | 16 |
| Terminated | 14 |
| Recruiting | 10 |
| Withdrawn | 5 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sangart | 4 |
| Assiut University | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| Gold Coast Hospital and Health Service | 2 |
| IRCCS Policlinico S. Donato | 2 |
| Jason Sperry | 2 |
| McMaster University | 2 |
| Northwell Health | 2 |
| Portola Pharmaceuticals | 2 |
| Queen Mary University of London | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 111 |
| Wounds and Injuries | 13 |
| Thrombosis | 9 |
| Hemostatic Disorders | 7 |
| Shock, Hemorrhagic | 6 |
| Thrombocytopenia | 6 |
| Blood Loss, Surgical | 4 |
| Coronary Artery Disease | 4 |
| Postpartum Hemorrhage | 4 |
| Stroke | 4 |
Trials
Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.
11 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.